Recruiting
Phase 1

Survivin Long Peptide Vaccine

Sponsor:

Roswell Park Cancer Institute

Code:

NCT03879694

Conditions

Lung Atypical Carcinoid Tumor

Lung Typical Carcinoid Tumor

Metastatic Pancreatic Neuroendocrine Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Incomplete Freund's Adjuvant

Octreotide Acetate

Sargramostim

SVN53-67/M57-KLH Peptide Vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Roswell Park Cancer Institute on 2024-12-18.